Tango Therapeutics Financial Overview
Tango Therapeutics's market cap is currently $1.17B. The company's EPS TTM is $0.14; its P/E ratio is -9.46; Tango Therapeutics is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
